beta-lapachone has been researched along with Adenocarcinoma, Alveolar in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J | 1 |
| Liu, M | 1 |
| Zhang, H | 1 |
| Guo, W | 1 |
1 other study available for beta-lapachone and Adenocarcinoma, Alveolar
| Article | Year |
|---|---|
High-Contrast Fluorescence Diagnosis of Cancer Cells/Tissues Based on β-Lapachone-Triggered ROS Amplification Specific in Cancer Cells.
Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Fluorescent Dyes; Humans; Microscopy, Confocal; Nap | 2021 |